816 related articles for article (PubMed ID: 24462240)
1. Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies.
Petit-Pedrol M; Armangue T; Peng X; Bataller L; Cellucci T; Davis R; McCracken L; Martinez-Hernandez E; Mason WP; Kruer MC; Ritacco DG; Grisold W; Meaney BF; Alcalá C; Sillevis-Smitt P; Titulaer MJ; Balice-Gordon R; Graus F; Dalmau J
Lancet Neurol; 2014 Mar; 13(3):276-86. PubMed ID: 24462240
[TBL] [Abstract][Full Text] [Related]
2. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study.
Gresa-Arribas N; Titulaer MJ; Torrents A; Aguilar E; McCracken L; Leypoldt F; Gleichman AJ; Balice-Gordon R; Rosenfeld MR; Lynch D; Graus F; Dalmau J
Lancet Neurol; 2014 Feb; 13(2):167-77. PubMed ID: 24360484
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen.
Lancaster E; Lai M; Peng X; Hughes E; Constantinescu R; Raizer J; Friedman D; Skeen MB; Grisold W; Kimura A; Ohta K; Iizuka T; Guzman M; Graus F; Moss SJ; Balice-Gordon R; Dalmau J
Lancet Neurol; 2010 Jan; 9(1):67-76. PubMed ID: 19962348
[TBL] [Abstract][Full Text] [Related]
4. A new encephalitis with GABAA receptor antibodies.
Hirsch LJ
Lancet Neurol; 2014 Mar; 13(3):239-40. PubMed ID: 24462239
[No Abstract] [Full Text] [Related]
5. Investigations in GABA
Spatola M; Petit-Pedrol M; Simabukuro MM; Armangue T; Castro FJ; Barcelo Artigues MI; Julià Benique MR; Benson L; Gorman M; Felipe A; Caparó Oblitas RL; Rosenfeld MR; Graus F; Dalmau J
Neurology; 2017 Mar; 88(11):1012-1020. PubMed ID: 28202703
[TBL] [Abstract][Full Text] [Related]
6. Febrile infection-related epilepsy syndrome (FIRES) with super-refractory status epilepticus revealing autoimmune encephalitis due to GABA
Caputo D; Iorio R; Vigevano F; Fusco L
Eur J Paediatr Neurol; 2018 Jan; 22(1):182-185. PubMed ID: 29203057
[TBL] [Abstract][Full Text] [Related]
7. Encephalitis patient-derived monoclonal GABAA receptor antibodies cause epileptic seizures.
Kreye J; Wright SK; van Casteren A; Stöffler L; Machule ML; Reincke SM; Nikolaus M; van Hoof S; Sanchez-Sendin E; Homeyer MA; Cordero Gómez C; Kornau HC; Schmitz D; Kaindl AM; Boehm-Sturm P; Mueller S; Wilson MA; Upadhya MA; Dhangar DR; Greenhill S; Woodhall G; Turko P; Vida I; Garner CC; Wickel J; Geis C; Fukata Y; Fukata M; Prüss H
J Exp Med; 2021 Nov; 218(11):. PubMed ID: 34546336
[TBL] [Abstract][Full Text] [Related]
8. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.
Dalmau J; Gleichman AJ; Hughes EG; Rossi JE; Peng X; Lai M; Dessain SK; Rosenfeld MR; Balice-Gordon R; Lynch DR
Lancet Neurol; 2008 Dec; 7(12):1091-8. PubMed ID: 18851928
[TBL] [Abstract][Full Text] [Related]
9. Anti-gamma-aminobutyric acid receptor type A encephalitis: a review.
Guo CY; Gelfand JM; Geschwind MD
Curr Opin Neurol; 2020 Jun; 33(3):372-380. PubMed ID: 32374573
[TBL] [Abstract][Full Text] [Related]
10. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
Levite M
J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
[TBL] [Abstract][Full Text] [Related]
11. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.
Titulaer MJ; McCracken L; Gabilondo I; Armangué T; Glaser C; Iizuka T; Honig LS; Benseler SM; Kawachi I; Martinez-Hernandez E; Aguilar E; Gresa-Arribas N; Ryan-Florance N; Torrents A; Saiz A; Rosenfeld MR; Balice-Gordon R; Graus F; Dalmau J
Lancet Neurol; 2013 Feb; 12(2):157-65. PubMed ID: 23290630
[TBL] [Abstract][Full Text] [Related]
12. The potential role of astroglial GABA
Ismail FS; Faustmann PM
Epilepsia Open; 2023 Jun; 8(2):692-701. PubMed ID: 37078803
[TBL] [Abstract][Full Text] [Related]
13. CSF reactivity in GABA
Nikolaus M; Kreye J; Turko P; Vida I; Knierim E; Prüss H
Brain Res; 2019 Feb; 1704():249-256. PubMed ID: 30347219
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune epilepsy in children: case series and proposed guidelines for identification.
Suleiman J; Brilot F; Lang B; Vincent A; Dale RC
Epilepsia; 2013 Jun; 54(6):1036-45. PubMed ID: 23551014
[TBL] [Abstract][Full Text] [Related]
15. Antiglutamic acid decarboxylase antibodies in children with encephalitis and status epilepticus.
Lin JJ; Lin KL; Hsia SH; Wang HS; Chou IJ; Lin YT;
Pediatr Neurol; 2012 Oct; 47(4):252-8. PubMed ID: 22964438
[TBL] [Abstract][Full Text] [Related]
16. Febrile infection-related epilepsy syndrome without detectable autoantibodies and response to immunotherapy: a case series and discussion of epileptogenesis in FIRES.
van Baalen A; Häusler M; Plecko-Startinig B; Strautmanis J; Vlaho S; Gebhardt B; Rohr A; Abicht A; Kluger G; Stephani U; Probst C; Vincent A; Bien CG
Neuropediatrics; 2012 Aug; 43(4):209-16. PubMed ID: 22911482
[TBL] [Abstract][Full Text] [Related]
17. A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study.
Sabater L; Gaig C; Gelpi E; Bataller L; Lewerenz J; Torres-Vega E; Contreras A; Giometto B; Compta Y; Embid C; Vilaseca I; Iranzo A; Santamaría J; Dalmau J; Graus F
Lancet Neurol; 2014 Jun; 13(6):575-86. PubMed ID: 24703753
[TBL] [Abstract][Full Text] [Related]
18. Severe GABA
Nikolaus M; Knierim E; Meisel C; Kreye J; Prüss H; Schnabel D; Kallinich T
Eur J Paediatr Neurol; 2018 May; 22(3):558-562. PubMed ID: 29396172
[TBL] [Abstract][Full Text] [Related]
19. Refractory status epilepticus and autoimmune encephalitis with GABAAR and GAD65 antibodies: A case report.
Gagnon MM; Savard M; Mourabit Amari K
Seizure; 2016 Apr; 37():25-7. PubMed ID: 26921483
[TBL] [Abstract][Full Text] [Related]
20. GABA
Maniscalco GT; Mariotto S; Höftberger R; Capra R; Servillo G; Manzo V; Napolitano M; Candelaresi P; Gerevini S; Ferrari S; Bozzetti S; Spatola M; Florio C
Neurology; 2020 Sep; 95(9):399-401. PubMed ID: 32651290
[No Abstract] [Full Text] [Related]
[Next] [New Search]
